$HEAR
Turtle Beach Corp Stock $hear

$hear Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000095017024030883 Filed on March 13, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$55.85M	$99.54M	$258.1M
YoY Change	8.56%	-1.35%	7.48%
Cost Of Revenue	$38.06M	$67.73M	$182.6M
YoY Change	2.03%	-16.26%	-4.38%
Gross Profit	$17.79M	$31.80M	$75.50M
YoY Change	25.79%	58.88%	53.5%
Gross Profit Margin	31.85%	31.95%	29.25%
Selling, General & Admin	$14.69M	$18.98M	$74.81M
YoY Change	-11.15%	-13.38%	-6.07%
% of Gross Profit	82.58%	59.67%	99.08%
Research & Development	$3.902M	$4.467M	$17.14M
YoY Change	-4.85%	3.04%	-10.39%
% of Gross Profit	21.94%	14.05%	22.7%
Depreciation & Amortization	$916.0K	$1.166M	$3.800M
YoY Change	-6.34%	-13.76%	-17.39%
% of Gross Profit	5.15%	3.67%	5.03%
Operating Expenses	$23.50M	$23.45M	$91.95M
YoY Change	13.9%	-10.67%	-6.91%
Operating Profit	-$5.713M	$8.359M	-$16.44M
YoY Change	-12.0%	-234.26%	-66.84%
Interest Expense	-$150.0K	-$251.0K	$504.0K
YoY Change	-192.02%	-56.5%	-141.31%
% of Operating Profit		-3.0%
Other Income/Expense, Net	-$370.0K	$405.0K	-$394.0K
YoY Change	208.33%	-82.62%	-77.52%
Pretax Income	-$6.233M	$8.513M	-$17.34M
YoY Change	-8.0%	-233.66%	-68.15%
Income Tax	-$6.388M	-$39.00K	$338.0K
% Of Pretax Income		-0.46%
Net Earnings	$155.0K	$8.552M	-$17.68M
YoY Change	-102.31%	-136.81%	-70.31%
Net Earnings / Revenue	0.28%	8.59%	-6.85%
Basic Earnings Per Share	$0.01	$0.49	-$1.03
Diluted Earnings Per Share	$0.01	$0.47	-$1.03
COMMON SHARES
Basic Shares Outstanding	17.61M	17.40M	17.14M
Diluted Shares Outstanding	19.39M		17.14M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.82M	$18.73M	$18.73M
YoY Change	-13.4%	64.32%	64.32%
Cash & Equivalents	$17.82M	$18.73M	$18.73M
Short-Term Investments
Other Short-Term Assets	$10.32M	$7.720M	$7.720M
YoY Change	13.33%	-16.05%	-16.05%
Inventory	$69.53M	$44.02M	$44.02M
Prepaid Expenses
Receivables	$42.91M	$54.39M	$54.39M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$140.6M	$124.9M	$124.9M
YoY Change	18.28%	-7.64%	-7.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.533M	$4.824M	$11.83M
YoY Change	-9.94%	-24.17%	85.95%
Goodwill	$52.91M	$10.69M
YoY Change	395.11%	0.0%
Intangibles	$48.70M	$1.734M
YoY Change	1871.02%	-33.61%
Long-Term Investments
YoY Change
Other Assets	$1.239M	$862.0K	$862.0K
YoY Change	110.36%	-89.91%	-89.91%
Total Long-Term Assets	$117.8M	$25.11M	$25.11M
YoY Change	325.9%	-10.97%	-10.97%
TOTAL ASSETS
Total Short-Term Assets	$140.6M	$124.9M	$124.9M
Total Long-Term Assets	$117.8M	$25.11M	$25.11M
Total Assets	$258.4M	$150.0M	$150.0M
YoY Change	76.36%	-8.21%	-8.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$44.84M	$26.91M	$26.91M
YoY Change	104.88%	35.58%	35.58%
Accrued Expenses	$28.42M	$24.22M	$24.22M
YoY Change	4.54%	13.84%	13.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$76.79M	$56.33M	$56.33M
YoY Change	47.93%	-12.44%	-12.44%
LONG-TERM LIABILITIES
Long-Term Debt	$45.95M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$8.893M	$7.012M	$7.012M
YoY Change	15.45%	-12.76%	-12.76%
Total Long-Term Liabilities	$54.85M	$7.012M	$7.012M
YoY Change	612.02%	-12.76%	-12.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$76.79M	$56.33M	$56.33M
Total Long-Term Liabilities	$54.85M	$7.012M	$7.012M
Total Liabilities	$133.2M	$64.89M	$64.89M
YoY Change	115.66%	-12.84%	-12.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$134.1M	-$134.3M
YoY Change	8.77%	15.16%
Common Stock	$21.00K	$18.00K
YoY Change	23.53%	5.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$125.2M	$85.08M	$85.08M
YoY Change
Total Liabilities & Shareholders Equity	$258.4M	$150.0M	$150.0M
YoY Change	76.36%	-8.21%	-8.21%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$155.0K	$8.552M	-$17.68M
YoY Change	-102.31%	-136.81%	-70.31%
Depreciation, Depletion And Amortization	$916.0K	$1.166M	$3.800M
YoY Change	-6.34%	-13.76%	-17.39%
Cash From Operating Activities	$27.26M	$19.10M	$27.04M
YoY Change	-5.97%	-30.99%	-164.63%
INVESTING ACTIVITIES
Capital Expenditures	$731.0K	$235.0K	$2.159M
YoY Change	-17.59%	-85.79%	-39.17%
Acquisitions	$75.49M
YoY Change
Other Investing Activities	-$75.49M	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$76.23M	-$235.0K	-$2.159M
YoY Change	8493.57%	-85.79%	-39.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$974.0K
YoY Change			49.16%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	47.98M	-12.72M	-17.85M
YoY Change	-352.44%	-50.2%	-190.56%
NET CHANGE
Cash From Operating Activities	27.26M	19.10M	27.04M
Cash From Investing Activities	-76.23M	-235.0K	-2.159M
Cash From Financing Activities	47.98M	-12.72M	-17.85M
Net Change In Cash	-910.0K	6.147M	7.330M
YoY Change	-109.92%	1170.04%	-128.53%
FREE CASH FLOW
Cash From Operating Activities	$27.26M	$19.10M	$27.04M
Capital Expenditures	$731.0K	$235.0K	$2.159M
Free Cash Flow	$26.53M	$18.87M	$24.89M
YoY Change	-5.61%	-27.5%	-154.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001493761
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#GoodwillAndIntangibleAssetImpairment
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-35465
CY2023	dei	Entity Registrant Name EntityRegistrantName	TURTLE BEACH CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-2767540
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	44 South Broadway
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	4th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	White Plains
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10601
CY2023	dei	City Area Code CityAreaCode	888
CY2023	dei	Local Phone Number LocalPhoneNumber	496-8001
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2023	dei	Trading Symbol TradingSymbol	HEAR
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	196646827
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17605444
CY2023	dei	Auditor Firm AuditorFirmId	42
CY2023	dei	Auditor Name AuditorName	ERNST & YOUNG LLP
CY2023	dei	Auditor Location AuditorLocation	New York
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	258122000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240166000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	366354000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	182618000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	190979000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	237971000
CY2023	us-gaap	Gross Profit GrossProfit	75504000
CY2022	us-gaap	Gross Profit GrossProfit	49187000
CY2021	us-gaap	Gross Profit GrossProfit	128383000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	43489000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	47090000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	58883000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17137000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19123000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17490000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31321000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32558000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31579000
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	1896000
CY2023	us-gaap	Operating Expenses OperatingExpenses	91947000
CY2022	us-gaap	Operating Expenses OperatingExpenses	100667000
CY2021	us-gaap	Operating Expenses OperatingExpenses	107952000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-16443000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-51480000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	20431000
CY2023	us-gaap	Interest Expense InterestExpense	504000
CY2022	us-gaap	Interest Expense InterestExpense	1220000
CY2021	us-gaap	Interest Expense InterestExpense	383000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-394000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1753000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	101000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17341000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54453000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20149000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	338000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5093000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2428000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17679000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59546000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	17721000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.03
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.62
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.62
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.97
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17135000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16450000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15915000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17135000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16450000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18251000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17679000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59546000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	17721000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	545000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1521000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-462000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	545000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1521000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-462000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17134000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-61067000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17259000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18726000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11396000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37052000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37455000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	54390000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	43336000
CY2023Q4	us-gaap	Inventory Net InventoryNet	44019000
CY2022Q4	us-gaap	Inventory Net InventoryNet	71252000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7720000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9196000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	124855000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	135180000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4824000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6362000
CY2023Q4	us-gaap	Goodwill Goodwill	10686000
CY2022Q4	us-gaap	Goodwill Goodwill	10686000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1734000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2612000
CY2023Q4	us-gaap	Other Assets OtherAssets	7868000
CY2022Q4	us-gaap	Other Assets OtherAssets	8547000
CY2023Q4	us-gaap	Assets Assets	149967000
CY2022Q4	us-gaap	Assets Assets	163387000
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	19053000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	26908000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19846000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	29424000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	25433000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	56332000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	64332000
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1546000
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	2076000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7012000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8038000
CY2023Q4	us-gaap	Liabilities Liabilities	64890000
CY2022Q4	us-gaap	Liabilities Liabilities	74446000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17531702
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17531702
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16569173
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16569173
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	18000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	17000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	220185000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	206916000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-134277000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116598000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-849000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1394000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	85077000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	88941000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	149967000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	163387000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17679000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59546000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	17721000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3830000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4578000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4052000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1009000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1238000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1261000
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	141000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	189000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	189000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11983000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7984000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7656000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-44000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6202000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1119000
CY2023	hear	Revenue From Contract With Customer Sales Returns Reserve For Sales Returns RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns	-632000
CY2022	hear	Revenue From Contract With Customer Sales Returns Reserve For Sales Returns RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns	1180000
CY2021	hear	Revenue From Contract With Customer Sales Returns Reserve For Sales Returns RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns	2236000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-3000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-23000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	468000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	810000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	4829000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	1609000
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-1896000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1928000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5757000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4845000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-9682000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-27336000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-22100000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32240000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1772000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-23350000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2793000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1437000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6045000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6091000
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-283000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	727000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-5571000
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1860000
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-8690000
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	6775000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27044000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41846000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-327000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2159000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3549000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5621000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2500000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2159000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3549000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8121000
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	210210000
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	91945000
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	120858000
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	229263000
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	72892000
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	120858000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2261000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	653000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5289000
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	974000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4882000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	463000
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	80000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17846000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19706000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-56000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	291000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-635000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-457000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7330000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26324000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8961000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11396000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37720000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46681000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18726000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11396000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37720000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	500000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	979000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	194000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	63000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2380000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6561000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	133000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	390000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1189000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	116399000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	17721000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-462000
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	111000
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	463000
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4882000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5289000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7656000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	141369000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59546000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1521000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	655000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7984000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	88941000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17679000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	545000
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	974000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2261000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11983000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	85077000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	3900000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	4900000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Uses of Estimates</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to use estimates and assumptions that affect the reported amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. The significant estimates and assumptions used by management affect: sales return reserve, allowances for cash discounts, warranty reserve, valuation of inventory, valuation of long-lived assets, goodwill and other intangible assets, depreciation and amortization of long-lived assets, valuation of deferred tax assets, probability of performance shares vesting and forfeiture rates utilized in issuing stock-based compensation awards. The Company evaluates estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from these estimates, and those differences could be material to the consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023Q4	hear	Allowance For Cash Discounts AllowanceForCashDiscounts	28600000
CY2022Q4	hear	Allowance For Cash Discounts AllowanceForCashDiscounts	29500000
CY2023Q4	hear	Allowance For Sales Returns AllowanceForSalesReturns	8400000
CY2022Q4	hear	Allowance For Sales Returns AllowanceForSalesReturns	7800000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	9700000
CY2023	us-gaap	Cooperative Advertising Expense CooperativeAdvertisingExpense	5600000
CY2022	us-gaap	Cooperative Advertising Expense CooperativeAdvertisingExpense	4100000
CY2021	us-gaap	Cooperative Advertising Expense CooperativeAdvertisingExpense	7600000
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023Q4	us-gaap	Nonfinancial Liabilities Fair Value Disclosure NonfinancialLiabilitiesFairValueDisclosure	0
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of investments in cash, cash equivalents and accounts receivables. The Company is exposed to credit risk and liquidity risk in the event of default by the financial institutions or issuers of investments in excess of FDIC insured limits. The Company performs periodic evaluations of the relative credit standing of these financial institutions and limits the amount of credit exposure with any institution.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounts receivable are unsecured and represent amounts due based on contractual obligations of customers. The Company's </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">five</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> largest individual customers accounted for approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">69</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of our gross sales in 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">67</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of our gross sales in 2022, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">66</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#ff0000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of our gross sales in 2021. During 2023, the Company's </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">four</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> largest customers - Walmart, Target, Amazon, Best Buy - each accounted for between </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of consolidated gross sales. Additionally, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2023, these customers had open receivables greater than 10% of the total receivable balance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentrations of credit risk with respect to accounts receivable are mitigated by performing ongoing credit evaluations of customers to assess the probability of collection based on a number of factors, including past transaction experience with the customer, evaluation of their credit history, limiting the credit extended, and review of the invoicing terms of the contract. In addition, the Company has credit insurance in place through a third-party insurer against defaults by certain other domestic and international customers, subject to policy limits. The Company generally does not require customers to provide collateral to support accounts receivable. The Company has recorded an allowance for doubtful accounts for those receivables that were determined not to be collectible.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Foreign cash balances at December 31, 2023 and 2022 were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span></p>
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	43579000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	70407000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	440000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	845000
CY2023Q4	us-gaap	Inventory Net InventoryNet	44019000
CY2022Q4	us-gaap	Inventory Net InventoryNet	71252000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35740000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33812000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	30916000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27450000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4824000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6362000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3800000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4600000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4100000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3944000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4171000
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	3335000
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	4147000
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	5275000
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2527000
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	5206000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4159000
CY2023Q4	hear	Accrued Freight Current AccruedFreightCurrent	2917000
CY2022Q4	hear	Accrued Freight Current AccruedFreightCurrent	1746000
CY2023Q4	hear	Accrued Expenses Current AccruedExpensesCurrent	8747000
CY2022Q4	hear	Accrued Expenses Current AccruedExpensesCurrent	8683000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	29424000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	25433000
CY2021	hear	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	1928000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-394000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-1753000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-1827000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-394000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1753000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	101000
CY2023Q4	hear	Finite Lived Intangible Assets Foreign Currency Gross FiniteLivedIntangibleAssetsForeignCurrencyGross	1159000
CY2023Q4	hear	Finite Lived Intangible Assets Foreign Currency Accumulated Amortization FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization	1292000
CY2023Q4	hear	Finite Lived Intangible Assets Foreign Currency Net FiniteLivedIntangibleAssetsForeignCurrencyNet	-133000
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	11876000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10142000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1734000
CY2022Q4	hear	Finite Lived Intangible Assets Foreign Currency Gross FiniteLivedIntangibleAssetsForeignCurrencyGross	1375000
CY2022Q4	hear	Finite Lived Intangible Assets Foreign Currency Accumulated Amortization FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization	1344000
CY2022Q4	hear	Finite Lived Intangible Assets Foreign Currency Net FiniteLivedIntangibleAssetsForeignCurrencyNet	31000
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	11660000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9048000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2612000
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1900000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000.0
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1006000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	425000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	170000
CY2023Q4	hear	Finite Lived Intangible Assets Amortization Expense After Year Three FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree	0
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1601000
CY2022Q4	us-gaap	Goodwill Goodwill	10686000
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0
CY2023Q4	us-gaap	Goodwill Goodwill	10686000
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	600000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	1200000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	400000
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	100000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	200000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	200000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-579000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-511000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	8000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4667000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	701000
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	12000
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	4088000
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	190000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-539000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-762000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	769000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	17000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1602000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	346000
CY2023	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-522000
CY2022	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	840000
CY2021	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	1115000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	848000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	255000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1051000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-90000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	72000
CY2023	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	848000
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	165000
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	1123000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	338000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5093000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2428000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-20116000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-53947000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	15146000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2775000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-506000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5003000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17341000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54453000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20149000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3642000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11435000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4231000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-385000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2098000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	812000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	135000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	90000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-60000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2850000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	18353000
CY2023	hear	Effective Income Tax Rate Reconciliation Excess Tax Benefits EffectiveIncomeTaxRateReconciliationExcessTaxBenefits	287000
CY2022	hear	Effective Income Tax Rate Reconciliation Excess Tax Benefits EffectiveIncomeTaxRateReconciliationExcessTaxBenefits	-232000
CY2021	hear	Effective Income Tax Rate Reconciliation Excess Tax Benefits EffectiveIncomeTaxRateReconciliationExcessTaxBenefits	-2159000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	976000
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	-96000
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	-770000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	558000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	400000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	878000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	858000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	325000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	530000
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-330000
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-382000
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	673000
CY2023	hear	Income Tax Reconciliation Section162m IncomeTaxReconciliationSection162m	1237000
CY2022	hear	Income Tax Reconciliation Section162m IncomeTaxReconciliationSection162m	395000
CY2021	hear	Income Tax Reconciliation Section162m IncomeTaxReconciliationSection162m	634000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-18000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	477000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	391000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	338000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5093000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2428000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	4000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	4000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	764000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	897000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	1402000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	1268000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2789000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2254000
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1614000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1573000
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1434000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	2846000
CY2023Q4	hear	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	1977000
CY2022Q4	hear	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	2227000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8372000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7354000
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	6154000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3835000
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1754000
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2010000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	1524000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	1501000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	311000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	470000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1376000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	852000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21635000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18741000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22094000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19244000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	459000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	503000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	18400000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2800000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3002000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3415000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	128000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	150000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	158000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	32000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	321000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	814000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	400000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2284000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3002000
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	100000
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	300000
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2000000
CY2023Q4	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	300000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	700000
CY2023Q4	hear	Unrecognized Tax Benefits Inclusive Of Interest And Penalties UnrecognizedTaxBenefitsInclusiveOfInterestAndPenalties	2900000
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	600000
CY2023Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	16100000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.01
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17679000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59546000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	17721000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17135000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16450000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15915000
CY2021	hear	Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Awards IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockAwards	438000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1348000
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	550000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17135000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16450000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18251000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.03
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.62
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7984000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7656000
CY2023	hear	Share Based Compensation Expenses Related Payroll ShareBasedCompensationExpensesRelatedPayroll	4000000
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	300000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.62
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.97
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2778000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3118000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1015000
CY2019Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000.0
CY2021Q2	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2023-04-09
CY2023Q1	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P2Y
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	600000
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8400000
CY2023	hear	Sharebased Compensation Arrangement By Sharebased Payment Award Forfeiture Period After Ending Employment SharebasedCompensationArrangementBySharebasedPaymentAwardForfeiturePeriodAfterEndingEmployment	P90D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	550000
CY2023	hear	Share Based Compensation Arrangement By Share Based Payment Award Plan Amendment ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanAmendment	1049000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	21000
CY2023	hear	Forfeited Expired Restricted Stock Added Back ForfeitedExpiredRestrictedStockAddedBack	28000
CY2023	hear	Performance Based Restricted Stock Unearned PerformanceBasedRestrictedStockUnearned	94000
CY2023	hear	Performance Based Restricted Stock Granted PerformanceBasedRestrictedStockGranted	163000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1059000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11983000
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	200000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2200000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1577545
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.66
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M21D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2465015
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	515089
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.39
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	21004
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	16.45
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1041452
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.10
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M19D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3137285
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1040873
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.22
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y2M19D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	3136393
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	984120
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.23
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y1M2D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2975342
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3300000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	800000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	13600000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.89
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1000000.0
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4200000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2600000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	258122000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240166000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	366354000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4824000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6362000
CY2020Q2	hear	Number Of Shareholders NumberOfShareholders	8
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	618000
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	856000
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1039000
CY2023	us-gaap	Product Warranty Expense ProductWarrantyExpense	721000
CY2022	us-gaap	Product Warranty Expense ProductWarrantyExpense	380000
CY2021	us-gaap	Product Warranty Expense ProductWarrantyExpense	674000
CY2023	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	669000
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	618000
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	857000
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	670000
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	618000
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	856000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7006000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1251000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6481000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7732000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y9M18D
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1500000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1300000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1437000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1451000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1361000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1383000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1201000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1980000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8813000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1081000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7732000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51444000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47982000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59158000
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	99538000
CY2023Q1	us-gaap	Gross Profit GrossProfit	14139000
CY2023Q2	us-gaap	Gross Profit GrossProfit	11872000
CY2023Q3	us-gaap	Gross Profit GrossProfit	17689000
CY2023Q4	us-gaap	Gross Profit GrossProfit	31804000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6705000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-15920000
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3606000
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	8552000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.4
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.93
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.4
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46662000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41300000
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51304000
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	100900000
CY2022Q1	us-gaap	Gross Profit GrossProfit	14029000
CY2022Q2	us-gaap	Gross Profit GrossProfit	7882000
CY2022Q3	us-gaap	Gross Profit GrossProfit	7258000
CY2022Q4	us-gaap	Gross Profit GrossProfit	20018000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6476000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-17826000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12011000
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-23233000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.4
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.73
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.4
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.4
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.73
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.4
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	37052000
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	37455000
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	34728000

Files In Submission

Name	View Source	Status
0000950170-24-030883-index-headers.html	Edgar Link	pending
0000950170-24-030883-index.html	Edgar Link	pending
0000950170-24-030883.txt	Edgar Link	pending
0000950170-24-030883-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hear-20231231.htm	Edgar Link	pending
hear-20231231.xsd	Edgar Link	pending
hear-ex21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hear-20231231_htm.xml	Edgar Link	completed
hear-ex23_1.htm	Edgar Link	pending
hear-ex23_2.htm	Edgar Link	pending
hear-ex31_1.htm	Edgar Link	pending
hear-ex31_2.htm	Edgar Link	pending
hear-ex32_1.htm	Edgar Link	pending
hear-ex3_2.htm	Edgar Link	pending
hear-ex97_1.htm	Edgar Link	pending
img252864189_0.jpg	Edgar Link	pending
img252864189_1.jpg	Edgar Link	pending
img252864189_2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HEAR
Turtle Beach Corp Stock $hear

2024 Q1 Form 10-K Financial Statement

#000095017024030883 Filed on March 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HEAR Turtle Beach Corp Stock $hear

2024 Q1 Form 10-K Financial Statement

#000095017024030883 Filed on March 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HEAR
Turtle Beach Corp Stock $hear